Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,470,720

« Back to Dashboard

Which drugs does patent 7,470,720 protect, and when does it expire?

Patent 7,470,720 protects HALAVEN and is included in one NDA.

This patent has forty-one patent family members in twenty-two countries.

Summary for Patent: 7,470,720

Title:	Methods and compositions for use in treating cancer
Abstract:	The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
Inventor(s):	Littlefield; Bruce A. (Andover, MA), Towle; Murray J. (Auburn, NH)
Assignee:	Eisai R&D Management Co., Ltd. (Tokyo, JP)
Application Number:	10/687,526
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,470,720
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation;

Drugs Protected by US Patent 7,470,720

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eisai Inc	HALAVEN	eribulin mesylate	SOLUTION;INTRAVENOUS	201532-001	Nov 15, 2010		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,470,720

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	502932	➤ Sign Up
Australia	2003284242	➤ Sign Up
Australia	4573999	➤ Sign Up
Australia	762998	➤ Sign Up
Belgium	2011C028	➤ Sign Up
Brazil	9911326	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.